COVID in Winter: What to Expect and New Ideas
Past Event
event date
October 15, 2020 11:00 am ET

COVID in Winter: What to Expect and New Ideas

With information on COVID-19 evolving daily,  our expert physician panel shares their thoughts on what we can expect from the virus over the next several months. They will also discuss lessons learned from the past seven months. Their conversation addresses topics tied to antibodies, treatment best practices, racial inequalities, innovation, and more!


Dr. Michael Saag, one of the most influential infectious disease doctors in the country and who is frequently on a number of major media outlets including C-SPAN, CNN, NBC, ABC and The Washington Post (he also survived COVID-19 back in March) Dr. Ofole Mgbako, an infectious disease fellow at Columbia University Irving Medical Center in Harlem where racial disparities around Covid-19 are at the forefront  Dr. Gregory Katz, a cardiologist at Vassar Brothers Medical Center who will share his experiences (the good, the bad and the ugly) treating COVID-19 patients in the ICU at the height of the pandemic in New York City Harry Saag, MD, FACP, Co-founder and CEO, Roster Health; Hospitalist, NYU Langone Health

This episode of Bright Spots in Healthcare is sponsored by Knowledge to Practice (K2P), a leading provider of personalized, competency-based lifelong learning for practicing physicians, hospitals, and healthcare systems.

Through K2P’s advanced digital learning platform, practitioners can assess and maintain core medical competencies and keep pace with emerging medicine. Importantly, K2P’s solutions help transform patient care and mitigate risks across hospitals and healthcare systems.



Gregory Katz, MD

Cardiologist, Hudson Valley Heart Center Vassar Brothers Medical Center, a Nuvance Health affiliate

Dr. Katz joined Nuvance Health affiliate, The Heart Center in Poughkeepsie, NY in September 2019. He specializes in preventive cardiology, coronary artery disease, disorders of cholesterol, and metabolic syndrome, a group of conditions such as elevated blood pressure and sugar that occur together and increase your risk of heart disease stroke, and type 2 diabetes.

Prior to joining Nuvance, Dr. Katz earned his medical degree from New York University’s School of Medicine in Manhattan. He completed his fellowship in cardiovascular disease at New York University Langone Medical Center, also in Manhattan, and was awarded Fellow of the Year for three consecutive years during his fellowship.

At NYU Langone, he completed his internal medicine residency and was selected to serve as senior chief resident, an educational leadership role within the training program, in 2015.

His most recent research experience has examined cardiovascular disease in patients with lupus, an autoimmune disease that occurs when the body’s immune system attacks its own tissues and organs.

In addition, Dr. Katz has contributed to quality improvement efforts and the development of faster evaluation processes for patients who visit the emergency room with chest pain during his time at NYU Langone.

He has also been published in more than 15 scholarly publications, including book chapters and peer-reviewed articles.

Dr. Katz publishes an email newsletter featuring his thoughts on health, medicine and COVID-19.

Ofole Mgbako, MD

Postdoctoral Infectious Disease Clinical and Research Fellow, Columbia University Irving Medical Center

Ofole is a physician advocate for communities of color and the LGBTQ community, particularly those living with HIV. I am an internal medicine doctor and infectious disease specialist. He has held multiple leadership positions during medical school and internal medicine residency. I have a long track record of community service and volunteer work focused on justice in healthcare and vulnerable communities. My career is devoted to speaking directly to the impact of racism and homophobia in healthcare, and addressing healthcare disparities. Ofole completed his residency at NYU Langone Health. He earned his medical degree at the University of Pennsylvania.

Harry Saag, MD, FACP

Co-founder and CEO, Roster Health; Hospitalist, NYU Langone Health

Harry is a board-certified internal medicine physician and the CEO of Roster, a tech-enabled healthcare company assisting organizations’ transition to value-based care by redefining the ways in which care is delivered for high-risk, high-need patients.

Prior to Roster, Harry served as the Medical Director for Network Integration and Ambulatory Quality at NYU Langone Health. In this role, he led NYULH’s ambulatory quality program for over 2,000 physicians across more than 200 sites consisting of an Academic-based Faculty Group Practice as well as a Network of Federally Qualified Health Centers.

He was born and raised in Birmingham, Alabama, and received an Economics Degree from The University of Georgia. He then returned to his native Alabama where he received his medical degree from The University of Alabama – Birmingham before moving to New York where he completed his residency training in internal medicine at NYU School of Medicine and subsequently served as a Chief Resident. His work has been published in JAMA, JAMA Internal Medicine, and the Journal of General Internal Medicine among others.

Michael Saag, MD

Associate Dean for Global Health; Director, UAB Center for AIDS Research, Professor of Medicine, University of Alabama at Birmingham

Dr. Saag received a B.S. in chemistry with honors in 1977 Tulane University, earned his medical degree with honors from the University of Louisville, and completed his residency and infectious disease and molecular virology fellowship training at the University of Alabama at Birmingham. During the last 6 months of his fellowship, Dr. Saag conceived the concept of a comprehensive HIV outpatient (1917) clinic dedicated to the provision of interdisciplinary patient care in conjunction with the conduct of high quality clinical trials, translational science, and clinical outcomes research.  Within the clinic structure, he established a clinical trials unit, a data management center, and a Clinical Specimen Repository designed to support the activities of the newly established Center for AIDS Research at UAB.  In essence, the clinic became a “hub” for the clinical, basic science, and behavioral science investigators within the Center by creating a dynamic interface between the patients and the investigators. Dr. Saag has participated in many studies of antiretroviral therapy as well as novel treatments for opportunistic infections.  He has published over 450 articles in peer reviewed journals, including the first description of the use of viral load in clinical practice (Science, 1993), the first description of the rapid dynamics of viral replication (Nature, 1995), the first guidelines for use of viral load in practice (Nature Medicine, 1996), the first proof of concept of fusion inhibition as a therapeutic option (Nature Medicine, 1998), and directed the ‘first-in- patient’ studies of 7 of the 30 antiretroviral drugs currently on the market.  Dr. Saag Co-Edited a textbook entitled AIDS Therapy  (now in its 3rd edition) and currently serves as an Editor of the Sanford Guide for Antimicrobial Agents and the Sanford HIV Guide.  Dr. Saag serves on the International AIDS Society-USA Board of Directors, is a Past-President of the HIV Medical Association, is Chair of the IAS-USA Antiretroviral Therapy Guidelines panel, was a founding Co-Chair of the AASLD / IDSA  Hepatitis C Guidelines Panel, and a past-member of the HHS Guidelines Panel on Antiretroviral Therapy and the WHO Antiretroviral Therapy Guidelines panel. In 2014, he was the Castle-Connolly National Physician of the Year and was inducted into the Alabama Healthcare Hall of Fame. An accomplished teacher, Dr. Saag has been awarded Argus awards annually by the UAB medical students as Best Lecturer in the Patient, Doctor, and Society module.  Dr. Saag recently published a memoir entitled “Positive: One doctor’s encounters with death, life, and the US Healthcare system,” now in its second printing.

Watch Event


Related Events

Leveraging SDOH Outreach to Increase Dual Eligible Penetration
Health Equity and SDOH: Leveraging Data and Measures